<http://experiment.worldcat.org/entity/work/data/26115364.nt> <http://rdfs.org/ns/void#inDataset> <http://purl.oclc.org/dataset/WorldCat/Works> .
<http://experiment.worldcat.org/entity/work/data/26115364.nt> <http://schema.org/about> <http://worldcat.org/entity/work/id/26115364> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh91005431> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh2009008270> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh85082873> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.worldcat.org/fast/625200> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.worldcat.org/fast/1749120> .
<http://worldcat.org/entity/work/id/26115364> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/Book> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/name> "Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991"@en .
<http://worldcat.org/entity/work/id/26115364> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://schema.org/CreativeWork> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/creator> <http://id.loc.gov/authorities/names/n87859806> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.worldcat.org/fast/898879> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/workExample> <http://www.worldcat.org/oclc/26348888> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh2008102459> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/name> "Marketing of Clozaril improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March, 5, 1991"@en .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/names/n86015838> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/creator> <http://viaf.org/viaf/153701656> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh85118163> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/workExample> <http://www.worldcat.org/oclc/853255846> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh2008107608> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh89002390> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.worldcat.org/fast/1204155> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.loc.gov/authorities/subjects/sh91005516> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/workExample> <http://www.worldcat.org/oclc/682100076> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/workExample> <http://www.worldcat.org/oclc/24603103> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://id.worldcat.org/fast/1013768> .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/name> "Marketing of Clozaril improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991"@en .
<http://worldcat.org/entity/work/id/26115364> <http://schema.org/about> <http://viaf.org/viaf/140800832> .